Position in NTRA
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,085
+$286 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#821
of 844 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Triumph Capital Management holds $305,694 across 12 Diagnostics & Research names. NTRA ranks #10 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
439 | $220,097 | |
| 2 | DHR |
Danaher Corp /De/
|
166 | $31,619 | |
| 3 | RVTY |
Revvity, Inc.
|
141 | $15,687 | |
| 4 | A |
Agilent Technologies, Inc.
|
99 | $13,150 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
18 | $9,475 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
11 | $5,825 | |
| 7 | DGX |
Quest Diagnostics Inc
|
22 | $4,662 | |
| 8 | WAT |
Waters Corp /De/
|
6 | $2,250 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,085 | 4 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $799 | 4 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||